Curation ALS1 NIPA1
2 + 1 = 3 / 18
Genetic evidence
Total: 2
Category | Type | Citation | Score | Details |
|---|---|---|---|---|
Singular Evidence | Probands | 0 | 6 patients with the NIPA1 expansion, co-occuring with a C9orf72 expansion. The source reports cohort-level NIPA1 repeat genotyping but does not describe individual NIPA1-expanded ALS probands with phenotype, family, or functional details suitable for singular proband scoring. Therefore, a score of 0 is assigned for this evidence. | |
Collective Evidence | Computational | 0 | ExpansionHunter WGS analysis of Southern African ALS cases and African controls found similar NIPA1 GCG-repeat distributions (p = 0.67); long alleles (≥9 GCG repeats) were rare in Africans and not associated with ALS, while 9–10-repeat alleles were more common in European than African controls (6% vs 0.4%, p = 0.016). Score of 0 assigned as this evidence does not support an association between the NIPA1 repeat and ALS. | |
Statistics | Case-control data | 2 | Project MinE STR analysis found NIPA1 ≥9-repeat alleles in 232 ALS cases (4.6%) and 78 controls (4.6%), with no significant ALS susceptibility association; NIPA1 showed only a nominal survival association. They used two methods of variant detection. |
Experimental evidence
Total: 1
Category | Type | Citation | Score | Details |
|---|---|---|---|---|
Function | Protein interaction | 1 | Authors found altered protein to protein interactions and sequesteration of RNA-binding protein. |